Figure 2. Dymista® is twice as effective as intranasal FP and AZE in relieving overall nasal and ocular symptoms in moderate/severe seasonal allergic rhinitis patients. The precision of these estimates is indicated by the upper bounds of the respective 95% confidence intervals. † p=0.0013 versus Dymista®; ‡ p=0.0004 versus Dymista®. Dymista®: n=153; FP: n=151; AZE: n=152. Modified from Meltzer et al, 2013 (S Karger AG, Basel)11